We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+2.84%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$37.8B
AUM Growth
+$858M
Cap. Flow
+$54.1M
Cap. Flow %
0.14%
Top 10 Hldgs %
5.01%
Holding
2,954
New
116
Increased
1,159
Reduced
1,473
Closed
125

Top Buys

Rank Stock Value
1
IT icon
Gartner
IT
+$57.5M
2
ALGN icon
Align Technology
ALGN
+$53.5M
3
DXC icon
DXC Technology
DXC
+$51.9M
4
ANSS
Ansys
ANSS
+$46.1M
5
EG icon
Everest Group
EG
+$34.5M

Sector Composition

Rank Sector Weight
1 Technology 13.9%
2 Financials 12.99%
3 Healthcare 12.28%
4 Industrials 11.03%
5 Consumer Discretionary 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
126
DELISTED
Alexion Pharmaceuticals
ALXN
$67.6M 0.18%
555,343
+124,968
+29% +$14.5M
EL icon
127
Estee Lauder
EL
$29.6B
$67.5M 0.18%
703,750
-46,748
-6% -$4.29M
HUM icon
128
Humana
HUM
$46.1B
$67.4M 0.18%
280,159
+17,887
+7% +$4.05M
BDX icon
129
Becton Dickinson
BDX
$44.1B
$66.9M 0.18%
351,627
-5,783
-2% -$1.06M
AIZ icon
130
Assurant
AIZ
$13.8B
$66.5M 0.18%
641,637
-15,015
-2% -$1.5M
TT icon
131
Trane Technologies
TT
$105B
$66.5M 0.18%
727,137
-27,122
-4% -$2.38M
AEE icon
132
Ameren
AEE
$31B
$66.2M 0.18%
1,211,532
-37,769
-3% -$2.1M
DRI icon
133
Darden Restaurants
DRI
$23.4B
$66.2M 0.18%
731,441
-65,714
-8% -$5.74M
CSRA
134
DELISTED
CSRA Inc.
CSRA
$65.9M 0.17%
2,075,991
+48,628
+2% +$1.46M
BFH icon
135
Bread Financial
BFH
$4.32B
$65.6M 0.17%
320,380
+35,245
+12% +$7M
ICE icon
136
Intercontinental Exchange
ICE
$83.5B
$65.4M 0.17%
992,496
-66,421
-6% -$4.07M
EW icon
137
Edwards Lifesciences
EW
$48.1B
$65.4M 0.17%
1,659,090
-133,344
-7% -$4.87M
SPGI icon
138
S&P Global
SPGI
$130B
$65.2M 0.17%
446,640
-22,917
-5% -$3.18M
NFLX icon
139
Netflix
NFLX
$296B
$65.2M 0.17%
4,361,610
+135,730
+3% +$2.09M
MU icon
140
Micron Technology
MU
$981B
$65.1M 0.17%
2,180,575
-605,222
-22% -$17.7M
AGN
141
DELISTED
Allergan plc
AGN
$65.1M 0.17%
267,683
-10,778
-4% -$2.53M
HRL icon
142
Hormel Foods
HRL
$14.3B
$65.1M 0.17%
1,907,463
+155,451
+9% +$5.36M
GE icon
143
GE Aerospace
GE
$373B
$64.9M 0.17%
501,622
+34,091
+7% +$4.67M
WU icon
144
Western Union
WU
$2.58B
$64.8M 0.17%
3,402,907
+232,925
+7% +$4.51M
CL icon
145
Colgate-Palmolive
CL
$73.4B
$64.7M 0.17%
872,335
-13,284
-1% -$986K
SJM icon
146
J.M. Smucker
SJM
$12.9B
$64.3M 0.17%
543,641
+104,749
+24% +$13.2M
FE icon
147
FirstEnergy
FE
$28.5B
$64.2M 0.17%
2,200,819
+248,439
+13% +$7.38M
HST icon
148
Host Hotels & Resorts
HST
$17B
$64.1M 0.17%
3,510,210
+66,744
+2% +$1.22M
VRTX icon
149
Vertex Pharmaceuticals
VRTX
$122B
$64.1M 0.17%
497,551
-72,719
-13% -$8.75M
DGX icon
150
Quest Diagnostics
DGX
$25.5B
$64.1M 0.17%
576,798
-25,067
-4% -$2.65M

Similar funds

Guggenheim Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Guggenheim Capital held 2,954 positions worth $37.8B, up 2.3% from $36.9B the previous quarter. Its ten largest holdings account for 5% of the portfolio.

Guggenheim Capital's Q2 2017 filing shows 116 new, 1,159 increased, 1,473 reduced and 125 closed positions. Its largest new stake was DXC Technology: 781,396 shares worth $51.9M. The largest sale was Yahoo Inc, an estimated $55.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Guggenheim Capital's largest Q2 2017 buy was DXC Technology: 781,396 shares worth $51.9M.
  • Guggenheim Capital added most to Gartner in Q2 2017, an estimated $57.5M increase.
  • Guggenheim Capital's biggest Q2 2017 reduction was Teradata, cutting an estimated $40.2M.
  • Guggenheim Capital fully exited Yahoo Inc in Q2 2017, selling an estimated $55.8M.
  • Guggenheim Capital's ten largest holdings make up 5% of its $37.8B portfolio in Q2 2017.
  • Guggenheim Capital opened 116 new positions and closed 125 in Q2 2017.
  • Guggenheim Capital's portfolio value rose 2.3% quarter-over-quarter to $37.8B.

Based on Guggenheim Capital's 13F filing for Q2 2017, filed 14 Aug 2017.